Technical420 Site Search

Last week, Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced an important milestone as it relates to its balance sheet and entered into a credit agreement for a US$750 million (USD) senior secured term loan. Under the terms of the credit agreement, Canopy Growth can obtain up to an additional…

Last week, HEXO Corporation (HEXO.TO) (HEXO) released second quarter financial results and the market initially responded favorably to the numbers, sending the stock more than 10% higher in pre-market trading. After the market opened, the positive trend quickly reversed course and HEXO ended the day down more than 5%. The…

HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced Trent MacDonald, Chief Financial Officer, will host a live AMA, ‘Ask Me Anything’, on Reddit alongside the Cannalysts, who manage one of Reddit’s most popular locations for Cannabis Insights and Analysis, on March 24, 2021, at 6:00 p.m.…

HEXO Corp. (TSX: HEXO; NYSE: HEXO) (“HEXO” or the "Company") today reported its financial results for the second quarter fiscal 2021 ended January 31, 2021 (“2Q21”). All amounts are expressed in Canadian dollars unless otherwise noted. "I am so proud of the entire HEXO team for the role they played…

Next month, Aphria Inc. (TSX: APHA) (Nasdaq: APHA) will have a special shareholder meeting to vote on the previously announced merger with Tilray, Inc. (Nasdaq: TLRY). We expect shareholders to approve the business combination and believe the market has already priced in this outcome. During the last month, both Aphria…

) (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, are pleased to announce that: (i) Aphria has obtained an interim order (the " Interim Order ") of the Ontario Superior Court of Justice (Commercial List) (the " Court ") in connection with its proposed business combination with…

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF), a global leader in specialized, research-driven cannabis extraction, distillation and derivative products, is pleased to announce its wholly owned subsidiary, MediPharm Labs Australia Pty Ltd (“MediPharm Labs Australia”), has entered into a new GMP white-label supply and contract manufacturing agreement with Cannim Australia…

In any emerging market, one of the best ways to assess the progress of a new industry is through Wall Street analyst coverage. The cannabis sector is a prime example as we have seen a steady increase in the number of banks that are covering the industry. Although a majority…

For years, we have been highlighting the growth of the US cannabis market and continue to view it as a more attractive investment opportunity when compared to the Canadian market. During the last year, US cannabis operators have reported explosive growth, and this has caught the attention of several large…

The cannabis sector received a jolt of good news when Canopy Growth Corporation (WEED.TO) (CGC) announced a multi-faceted strategy to capitalize on the US cannabidiol (CBD) beverage market. Over the next year, we expect Canopy Growth to benefit from its strategic partnership with Constellation Brands (STZ), a multi-national beverage conglomerate…